Care from Home program: a comprehensive community-based care coordination for management of paediatric asthma (CoMPAs) project

INTERVENTION: Interventions of this study will be implemented over a period of 12 months. Each participating child will be provided with the following interventions after discharged from asthma‐related hospitalizations: 1. Asthma resource package which will include: (a) copy of "Asthma and Your child: a resource pack for parents and carers" developed by the Aiming for Asthma Improvement in Children (AAIC) team at the Sydney Children's Hospital Randwick. It contains the standardized asthma information aimed at improving parent's/carer's understanding of asthma e.g. symptom recognition, basic physiology of asthma etc; (b) a letter for the general practitioner (GP) informing them of the child's recent hospital visits and clinical best practice and clinical asthma management tips; (c) a letter for school or childcare services informing them of the child's asthma‐related hospitalizations and provided access to online options on asthma management training for school/childcare staff; (d) individualized asthma action plan completed by the treating doctor at the hospital; (e) written discharge instructions for parents/carers which will include recommendation for medical follow‐up with a GP or paediatrician within 3 days after discharged from the hospital, advice to receive influenza vaccine, information on access to the Asthma Australia Helpline and link to online free asthma education sessions. The Asthma resource package will be given to patients or their parents/carers upon their discharge by the hospital staff. 2. After the participants were discharged from the hospital, the care coordinator of the research team will email discharge instructions and clinical best practice asthma tips to the respective primary care providers/GPs. 3. An automated reminder text message will be CONDITION: asthma; ; asthma Respiratory ‐ Asthma PRIMARY OUTCOME: Number of ED visits in the preceding 6 months as assessed by study‐specific, self‐reporting questionnaire.[Questionnaire will be administered at baseline, 6‐month and 12‐month after participants enrolled in the study.] Number of GP clinic visits in the preceding 6 months as assessed by study‐specific, self‐reporting questionnaire.[Questionnaire will be administered at baseline, 6‐month and 12‐month after participants enrolled in the study.] Number of hospital admissions in the preceding 6 months as assessed by study‐specific,self‐reporting questionnaire.[Questionnaire will be administered at baseline, 6‐month and 12‐month after participants enrolled in the study.] INCLUSION CRITERIA: Key inclusion criteria are: ‐ Children aged between 5‐16 years old. ‐ Children with any ED visits or hospital admission for asthma/VIW‐related illnesses ‐ Children attended ED or admitted to general paediatric ward at the Liverpool Hospital during the study period. SECONDARY OUTCOME: Asthma control score as measured by Asthma Control Questionnaire (ACT) or Childhood Asthma Control test (C‐ACT) questionnaire[Questionnaire will be administered at baseline, 6‐month and 12‐month after participants enrolled in the study.] Level of parental satisfaction with the intervention (intervention group only) as assessed by a study‐specific self‐reporting evaluation questionnaire.[This questionnaire will be administered at 12‐month after participants enrolled in the study.] Number of days missed from school by the child in the preceding 6 months as assessed by study‐specific, self‐reporting questionnaire.[Questionnaire will be administered at baseline, 6‐month and 12‐month after participants enrolled in the study.] Number of days missed from work by parents/carers due to their child's asthma in the preceding 6 months, as assessed by study‐specific,self‐reporting questionnaire[Questionnaire will be administered at baseline, 6‐month and 12‐month after participants enrolled in the study.] Number of days of asthma‐related activity limitations of the child in the preceding 14 days, as assessed by study‐specific,self‐reporting questionnaire.[Questionnaire will be administered at baseline, 6‐month and 12‐month time after participants enrolled in the study.] Number of days requiring oral corticosteroid e.g prednisone in the preceding 6 months, as assessed by study‐specific, self‐reporting questionnaire.[Questionnaire will be administered at baseline, 6‐month and 12‐month after participants enrolled in the study.] Quality of life as measured by mini Paediatric Asthma Quality of Life Questionnaire (miniPAQLQ)[Questionnaire will be administered at baseline, 6‐month and 12‐month after participants enrolled in the study.]